/
ICU
$3.55+$0.43 (+13.78%)live
Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$12.5M
4M shares
52-week range
$2.07 – $12.50
14% from low
Sector
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Exchange
NASDAQ
CS
Borrow rate
5.50%
Hard to borrow
Price (6 mo)
Loading chart…
Change$-2716.45
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $135.0K | $1.2M |
| Cost of revenue | $0 | $0 | $0 | $0 | $0 | $53.0K |
| Gross profit | $0 | $0 | $0 | $0 | $135.0K | $1.2M |
| Gross margin | — | — | — | — | 100.0% | 95.7% |
| R&D | $4.0M | $2.8M | $2.5M | $6.0M | $9.1M | $7.5M |
| Operating income | −$6.5M | −$4.4M | −$11.6M | −$14.2M | −$17.8M | −$12.2M |
| EBITDA | $0 | −$4.4M | −$11.6M | −$11.1M | −$24.6M | −$12.2M |
| Net income | −$3.3M | −$4.6M | −$12.2M | −$26.2M | −$24.8M | −$12.2M |
| Net margin | — | — | — | — | -18392.6% | -984.6% |
| EPS (diluted) | -0.10 | -88.10 | -233.80 | -302.62 | -66.30 | -5.86 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $2M | $-3.64 | $-3.70–$-3.58 | 1 |
| 2027 | $3M | $-2.33 | $-2.37–$-2.30 | 1 |
| 2028 | $16M | $-0.76 | $-0.77–$-0.75 | 1 |
Forward consensus · source: Financial Modeling Prep
DCF fair valuemodel estimate
Intrinsic value
$3.75
Price
$3.55
Implied upside
+6%
Peer comparison
SeaStar Medical Holding Corporation Common Stock
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.
www.seastarmedical.com- Employees
- 17
- IPO / List date
- Oct 31, 2022
- HQ
- DENVER, CO
Held by traders on TradeandTell
No one on the platform currently holds ICU.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in ICU as of their last filing.
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2026-01-05 | 1-for-10reverse |
| 2024-06-10 | 1-for-25reverse |
Recent trades on TradeandTell
No one on the platform has traded ICU yet.
